Recent Posts
- A Letter to Our Biopharma Clients About Organizational Changes
- Video Transcript: PBMI Specialty Rx Forum on Maintaining Patient Centeredness
- Video Transcript: McKesson’s Paula Bickley on Maintaining Patient Centeredness
- GAVRETO™ (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson
- INQOVI (cedazuridine and decitabine), FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson